|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM360525091 |
| 003 |
DE-627 |
| 005 |
20231226083210.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2023 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1021/acs.langmuir.3c01715
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1201.xml
|
| 035 |
|
|
|a (DE-627)NLM360525091
|
| 035 |
|
|
|a (NLM)37552874
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Bhosale, Sneha R
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Bioderived Mesoporous CarbonTungsten Oxide Nanocomposite as a Drug Carrier Vehicle of Doxorubicin for Potent Cancer Therapy
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 23.08.2023
|
| 500 |
|
|
|a Date Revised 24.08.2023
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Scientists have investigated the possibility of employing nanomaterials as drug carriers. These nanomaterials can preserve their content and transport it to the target region in the body. In this investigation, we proposed a simple method for developing distinctive, bioderived nanostructures with mesoporous carbon nanoparticles impregnated with tungsten oxide (WO3). Prior to characterizing and encapsulating WO3 with bioderived mesoporous carbon, the anticancer drug doxorubicin (DOX) was added to the nanoparticles and examined loading and release study. The approaches for both nanoparticle production and characterization are discussed in detail. Colloidal qualities of the nanomaterial can be effectively preserved while also allowing transdermal transportation of nanoparticles into the body by forming them into green, reusable, and porous nanostructures. Although the theories of nanoparticles and bioderived carbon each have been studied separately, the combination presents a new route to applications connected to nanomedicine. Furthermore, this sample was used to study exotic biomedical applications, such as antioxidant, antimicrobial, and anticancer activities. The W-3 sample had lower antioxidant activity (44.01%) than the CW sample (56.34%), which was the most potent. A high DOX entrapment effectiveness of 97% was eventually achieved by the C@W sample, compared to a pure WO3 entrapment efficiency of 91%. It was observed that the Carbon/WO3 composite (C@W) sample showed more efficacy because the mesoporous carbon composition with WO3 increases the average surface area and surface-active locations
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Drug Carriers
|2 NLM
|
| 650 |
|
7 |
|a tungsten oxide
|2 NLM
|
| 650 |
|
7 |
|a 940E10M08M
|2 NLM
|
| 650 |
|
7 |
|a Carbon
|2 NLM
|
| 650 |
|
7 |
|a 7440-44-0
|2 NLM
|
| 650 |
|
7 |
|a Doxorubicin
|2 NLM
|
| 650 |
|
7 |
|a 80168379AG
|2 NLM
|
| 700 |
1 |
|
|a Bhosale, Rakhee R
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Patil, Devashree N
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Dhavale, Rushikesh P
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kolekar, Govind B
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Shimpale, Vinod B
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Anbhule, Prashant V
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1992
|g 39(2023), 33 vom: 22. Aug., Seite 11910-11924
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
| 773 |
1 |
8 |
|g volume:39
|g year:2023
|g number:33
|g day:22
|g month:08
|g pages:11910-11924
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.3c01715
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_721
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 39
|j 2023
|e 33
|b 22
|c 08
|h 11910-11924
|